We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+8.81%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$30.1B
AUM Growth
+$1.02B
Cap. Flow
-$1.16B
Cap. Flow %
-3.87%
Top 10 Hldgs %
22.79%
Holding
1,200
New
104
Increased
364
Reduced
497
Closed
122

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$50.1M
2
CSCO icon
Cisco
CSCO
+$39.1M
3
EW icon
Edwards Lifesciences
EW
+$38.9M
4
ETN icon
Eaton
ETN
+$37.7M
5
BAC icon
Bank of America
BAC
+$36.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$92.9M
2
TXN icon
Texas Instruments
TXN
+$67.4M
3
PFE icon
Pfizer
PFE
+$57.7M
4
FIS icon
Fidelity National Information Services
FIS
+$56.9M
5
TSLA icon
Tesla
TSLA
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 33.71%
2 Healthcare 19.22%
3 Consumer Discretionary 11.86%
4 Financials 8.66%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUE icon
501
Nucor
NUE
$58.3B
$5.74M 0.02%
+35,020
New +$5.11M
SEE
502
DELISTED
Sealed Air
SEE
$5.74M 0.02%
143,522
-53,258
-27% -$2.26M
ENS icon
503
EnerSys
ENS
$6.43B
$5.74M 0.02%
52,900
-3,000
-5% -$274K
CSL icon
504
Carlisle Companies
CSL
$13.5B
$5.73M 0.02%
22,334
-1,485
-6% -$329K
KMI icon
505
Kinder Morgan
KMI
$70.9B
$5.73M 0.02%
332,466
-3,183
-0.9% -$54.1K
BN icon
506
Brookfield
BN
$102B
$5.69M 0.02%
253,815
-2,048
-0.8% -$43.4K
ED icon
507
Consolidated Edison
ED
$41.4B
$5.69M 0.02%
62,978
+4,380
+7% +$419K
ROK icon
508
Rockwell Automation
ROK
$51.1B
$5.6M 0.02%
16,999
-5,343
-24% -$1.54M
FANG icon
509
Diamondback Energy
FANG
$56B
$5.59M 0.02%
42,535
-48,925
-53% -$6.55M
MDRX
510
DELISTED
Veradigm Inc. Common Stock
MDRX
$5.58M 0.02%
443,025
-113,516
-20% -$1.38M
QRVO icon
511
Qorvo
QRVO
$7.9B
$5.58M 0.02%
54,695
+266
+0.5% +$25.5K
WMS icon
512
Advanced Drainage Systems
WMS
$10.6B
$5.57M 0.02%
+48,978
New +$4.62M
MMSI icon
513
Merit Medical Systems
MMSI
$4.82B
$5.51M 0.02%
+65,900
New +$5.36M
DG icon
514
Dollar General
DG
$28.4B
$5.49M 0.02%
32,348
-208
-0.6% -$41.1K
VRNA
515
DELISTED
Verona Pharma
VRNA
$5.39M 0.02%
+254,759
New +$5.43M
DYN icon
516
Dyne Therapeutics
DYN
$4.68B
$5.37M 0.02%
477,730
+53,617
+13% +$633K
EYE icon
517
National Vision
EYE
$1.76B
$5.37M 0.02%
220,887
+4,682
+2% +$109K
CPB icon
518
Campbell Soup
CPB
$6.85B
$5.36M 0.02%
117,325
-7,565
-6% -$390K
SSNC icon
519
SS&C Technologies
SSNC
$18.9B
$5.35M 0.02%
88,219
-963
-1% -$54.8K
BILL icon
520
BILL Holdings
BILL
$4.72B
$5.31M 0.02%
45,405
+27
+0.1% +$2.56K
NVST icon
521
Envista
NVST
$4.62B
$5.26M 0.02%
155,400
STNE icon
522
StoneCo
STNE
$2.67B
$5.24M 0.02%
411,617
-38,643
-9% -$482K
TTD icon
523
Trade Desk
TTD
$8.97B
$5.24M 0.02%
67,902
+25,458
+60% +$1.72M
CEG icon
524
Constellation Energy
CEG
$92.1B
$5.19M 0.02%
56,741
-3,587
-6% -$297K
CHRW icon
525
C.H. Robinson
CHRW
$20.5B
$5.19M 0.02%
55,041
-434
-0.8% -$42K

Similar funds

Axa's Q2 2023 Portfolio in Review

As of Q2 2023, Axa held 1,200 positions worth $30.1B, up 3.5% from $29.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa withdrew a net $1.16B in Q2 2023, closing 122 positions and reducing 497 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in Lincoln Electric worth $19.9M.

  • Axa's largest Q2 2023 buy was Lincoln Electric: 100,054 shares worth $19.9M.
  • Axa added most to Intuit in Q2 2023, an estimated $50.1M increase.
  • Axa's biggest Q2 2023 reduction was Apple, cutting an estimated $92.9M.
  • Axa fully exited Vanguard S&P 500 ETF in Q2 2023, selling an estimated $44.8M.
  • Axa's ten largest holdings make up 23% of its $30.1B portfolio in Q2 2023.
  • Axa opened 104 new positions and closed 122 in Q2 2023.
  • Axa's portfolio value rose 3.5% quarter-over-quarter to $30.1B.

Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.